Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19
Clinical trial NCT04776044 · TERMINATED
Trial details
- NCT number
- NCT04776044
- Sponsor
- Atriva Therapeutics GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2022-06-06
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.